Loading...
ELEV ELEVATION ONCOLOGY INC Product Launches 8-K Filing
Back
LVTN
LV
ELEVATION ONCOLOGY INC
(ELEV)
Follow
FY2023 8 K
View More
Back
LVTN
LV
ELEVATION ONCOLOGY INC
(ELEV)
Follow
FY2023 8 K
Filing:
8 K
Published on:
5 Jun '23
Loan Prepayment
4 Apr '25
Management Change
1 Apr '25
Corporate Restructuring
20 Mar '25
Nasdaq Compliance
19 Mar '25
Financial Results
6 Mar '25
Management Change
31 Jan '25
Clinical Trial Updates
13 Jan '25
Q3 Financial Results
6 Nov '24
Nasdaq Compliance Notice
20 Sep '24
Financial Results and Clini...
6 Aug '24
Annual Meeting Voting Results
14 Jun '24
Earnings Report
2 May '24
Resignation and Appointment
5 Apr '24
Financial Results Announcement
6 Mar '24
Compliance with Nasdaq List...
23 Jan '24
Appointment of Director
22 Jan '24
Program Updates and Milestones
5 Jan '24
Earnings Report
2 Nov '23
Delisting
22 Sep '23
Clinical Trial Initiation
16 Aug '23
Financial Results Announcement
3 Aug '23
Annual Meeting Approval
20 Jun '23
Agreement for Stock Issuance
9 Jun '23
Clinical Data Announcement
5 Jun '23
Financial Results Announcement
15 May '23
Announcement
17 Apr '23
Financial Results Announcement
9 Mar '23
Amendment to Bylaws
3 Mar '23
Financial Results, CEO Resi...
6 Jan '23
External Links:
SEC
AI Assistant
Close
ELEVATION ONCOLOGY INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.